MedPath

Randomized multicentre phase III study of short course radiation therapy followed by prolonged pre-operative chemotherapy and surgery in patients with high risk primary rectal cancer compared to standard preoperative chemoradiotherapy, surgery and optional adjuvant chemotherapy.

Completed
Conditions
Primary rectal cancer with high risk of failing locally and/or systemically.Keywords: rectal cancer, neoadjuvant chemotherapy, short course radiotherapy
Registration Number
NL-OMON24092
Lead Sponsor
niversity Medical Center Groningen, PO BOX 3001 , 9700 RB , Groningen , The Netherlands
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
885
Inclusion Criteria

Primary tumour characteristics:

1. Histological proof of newly diagnosed primary adenocarcinoma of the rectum;

Exclusion Criteria

1. Extensive growth into cranial part of the sacrum (above S3) or the lumbosacral nerve roots indicating that surgery will never be possible even if substantial tumour down-sizing is seen;

2. Presence of metastatic disease or recurrent rectal tumour;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease related Treatment Failure (3-years after surgery)
Secondary Outcome Measures
NameTimeMethod
1. Overall survival;<br /><br>2. CRM negative (margin > 1 mm) rate;<br /><br>3. Pathological complete response (pCR) rate;<br /><br>4. Short and long-term toxicity;<br /><br>5. Surgical complications;<br /><br>6. Quality of life.
© Copyright 2025. All Rights Reserved by MedPath